Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States

• Hauptverfasser: Jonathan I. Silverberg (Verfasst von), Feifei Yang (Verfasst von), Evo Alemao (Verfasst von), Jing Zhao (Verfasst von), Concetta Crivera (Verfasst von), Hetal V. Patel (Verfasst von), Iris Lin (Verfasst von), Aaron R. Mangold (Verfasst von)
• Format: Buch
• Veröffentlicht: Wiley, 2024-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background The potential association of long‐term oral corticosteroid (OCS) use with adverse events (AEs) in patients with bullous pemphigoid (BP) is not well characterized in a real‐world setting. Objectives To evaluate the effect of OCS use and treatment duration on the incident AEs in pa...